Results 111 to 120 of about 412,643 (184)

Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial

open access: yes, 2008
BACKGROUND: As type 2 diabetes mellitus progresses, oral hypoglycaemic agents often fail to maintain blood glucose control and insulin is needed. We investigated whether the addition of once-daily insulin glargine is non-inferior to three-times daily ...
Landgraf, W.   +5 more
core  

Ultra-rapid lispro or fast-acting aspart compared to standard insulin lispro and aspart using closed-loop insulin therapy: a systematic review and meta-analysis of randomized control trials. [PDF]

open access: yesFront Endocrinol (Lausanne)
Rakab MS   +11 more
europepmc   +1 more source

Management of Diabetes Mellitus: Defining the Role of Insulin Lispro Mix75/25 (Humalog(R) Mix75/25(TM))

open access: yes
Diabetes mellitus is a common metabolic disorder characterized by high blood glucose levels resulting from an insulin deficiency (type 1 diabetes mellitus) or a combination of insulin deficiency and insulin resistance (type 2 diabetes mellitus).
Christine R. Culy, Blair Jarvis
core  

Home - About - Disclaimer - Privacy